Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

VAMPr: VAriant Mapping and Prediction of antibiotic resistance via explainable features and machine learning.

Kim J, Greenberg DE, Pifer R, Jiang S, Xiao G, Shelburne SA, Koh A, Xie Y, Zhan X.

PLoS Comput Biol. 2020 Jan 13;16(1):e1007511. doi: 10.1371/journal.pcbi.1007511. eCollection 2020 Jan.

2.

Whole-genome sequencing of Staphylococcus epidermidis bloodstream isolates from a prospective clinical trial reveals that complicated bacteraemia is caused by a limited number of closely related sequence types.

Shelburne SA, Dib RW, Endres BT, Reitzel R, Li X, Kalia A, Sahasrabhojane P, Chaftari AM, Hachem R, Vargas-Cruz NS, Jiang Y, Garey K, Fowler VG Jr, Holland TL, Gu J, Miller W, Sakurai A, Arias CA, Aitken SL, Greenberg DE, Kim J, Flores AR, Raad I.

Clin Microbiol Infect. 2019 Oct 19. pii: S1198-743X(19)30535-X. doi: 10.1016/j.cmi.2019.10.008. [Epub ahead of print]

PMID:
31639470
3.

Combating resistance while maintaining innovation: the future of antimicrobial stewardship.

Vickers RJ, Bassetti M, Clancy CJ, Garey KW, Greenberg DE, Nguyen MH, Roblin D, Tillotson GS, Wilcox MH.

Future Microbiol. 2019 Oct;14:1331-1341. doi: 10.2217/fmb-2019-0227. Epub 2019 Sep 17.

4.

Optimizing Breast Pocket Irrigation: The Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Era.

Culbertson EJ, Felder-Scott C, Deva AK, Greenberg DE, Adams WP.

Aesthet Surg J. 2019 Sep 10. pii: sjz246. doi: 10.1093/asj/sjz246. [Epub ahead of print]

PMID:
31501857
5.

AcrAB-TolC Inhibition by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Antibiotic Activity in Vitro and in Vivo.

Sturge CR, Felder-Scott CF, Pifer R, Pybus C, Jain R, Geller BL, Greenberg DE.

ACS Infect Dis. 2019 Aug 9;5(8):1446-1455. doi: 10.1021/acsinfecdis.9b00123. Epub 2019 Jun 11.

PMID:
31119935
6.

Multidrug-resistant Pseudomonas aeruginosa from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime-avibactam.

Atkin SD, Abid S, Foster M, Bose M, Keller A, Hollaway R, Sader HS, Greenberg DE, Finklea JD, Castanheira M, Jain R.

Infect Drug Resist. 2018 Sep 17;11:1499-1510. doi: 10.2147/IDR.S173804. eCollection 2018.

7.

Fabrication and Microscopic and Spectroscopic Characterization of Cytocompatible Self-Assembling Antimicrobial Nanofibers.

Xu D, Chen W, Tobin-Miyaji YJ, Sturge CR, Yang S, Elmore B, Singh A, Pybus C, Greenberg DE, Sellati TJ, Qiang W, Dong H.

ACS Infect Dis. 2018 Sep 14;4(9):1327-1335. doi: 10.1021/acsinfecdis.8b00069. Epub 2018 Jul 9.

PMID:
29949345
8.

Remote acoustic sensing as a safety mechanism during exposure of metal implants to alternating magnetic fields.

Cheng B, Chatzinoff Y, Szczepanski D, Bing C, Shaikh S, Wyman O, Perry CE, Richardson JA, Burns DK, Evers BM, Greenberg DE, Chopra R.

PLoS One. 2018 May 10;13(5):e0197380. doi: 10.1371/journal.pone.0197380. eCollection 2018.

9.

Successful Treatment of Persistent Burkholderia cepacia Complex Bacteremia with Ceftazidime-Avibactam.

Tamma PD, Fan Y, Bergman Y, Sick-Samuels AC, Hsu AJ, Timp W, Simner PJ, Prokesch BC, Greenberg DE.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02213-17. doi: 10.1128/AAC.02213-17. Print 2018 Apr.

10.

Morpholino oligomers tested in vitro, in biofilm and in vivo against multidrug-resistant Klebsiella pneumoniae.

Geller BL, Li L, Martinez F, Sully E, Sturge CR, Daly SM, Pybus C, Greenberg DE.

J Antimicrob Chemother. 2018 Jun 1;73(6):1611-1619. doi: 10.1093/jac/dky058.

11.

Temperature-sensitive liposomal ciprofloxacin for the treatment of biofilm on infected metal implants using alternating magnetic fields.

Munaweera I, Shaikh S, Maples D, Nigatu AS, Sethuraman SN, Ranjan A, Greenberg DE, Chopra R.

Int J Hyperthermia. 2018 Mar;34(2):189-200. doi: 10.1080/02656736.2017.1422028.

12.

Antisense Inhibitors Retain Activity in Pulmonary Models of Burkholderia Infection.

Daly SM, Sturge CR, Marshall-Batty KR, Felder-Scott CF, Jain R, Geller BL, Greenberg DE.

ACS Infect Dis. 2018 May 11;4(5):806-814. doi: 10.1021/acsinfecdis.7b00235. Epub 2018 Mar 1.

13.

Antimicrobial Activity of Ibuprofen against Cystic Fibrosis-Associated Gram-Negative Pathogens.

Shah PN, Marshall-Batty KR, Smolen JA, Tagaev JA, Chen Q, Rodesney CA, Le HH, Gordon VD, Greenberg DE, Cannon CL.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e01574-17. doi: 10.1128/AAC.01574-17. Print 2018 Mar.

14.

MCR-1 Inhibition with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Sensitivity to Polymyxin in Escherichia coli.

Daly SM, Sturge CR, Felder-Scott CF, Geller BL, Greenberg DE.

mBio. 2017 Nov 7;8(6). pii: e01315-17. doi: 10.1128/mBio.01315-17.

15.

Employing high-frequency alternating magnetic fields for the non-invasive treatment of prosthetic joint infections.

Chopra R, Shaikh S, Chatzinoff Y, Munaweera I, Cheng B, Daly SM, Xi Y, Bing C, Burns D, Greenberg DE.

Sci Rep. 2017 Aug 8;7(1):7520. doi: 10.1038/s41598-017-07321-6.

16.

17β-Estradiol Dysregulates Innate Immune Responses to Pseudomonas aeruginosa Respiratory Infection and Is Modulated by Estrogen Receptor Antagonism.

Abid S, Xie S, Bose M, Shaul PW, Terada LS, Brody SL, Thomas PJ, Katzenellenbogen JA, Kim SH, Greenberg DE, Jain R.

Infect Immun. 2017 Sep 20;85(10). pii: e00422-17. doi: 10.1128/IAI.00422-17. Print 2017 Oct.

17.

Whole-Genome Sequencing Accurately Identifies Resistance to Extended-Spectrum β-Lactams for Major Gram-Negative Bacterial Pathogens.

Shelburne SA, Kim J, Munita JM, Sahasrabhojane P, Shields RK, Press EG, Li X, Arias CA, Cantarel B, Jiang Y, Kim MS, Aitken SL, Greenberg DE.

Clin Infect Dis. 2017 Sep 1;65(5):738-745. doi: 10.1093/cid/cix417.

18.

Inhibition of Bacterial Growth by Peptide-Conjugated Morpholino Oligomers.

Daly SM, Sturge CR, Greenberg DE.

Methods Mol Biol. 2017;1565:115-122. doi: 10.1007/978-1-4939-6817-6_10.

19.

The Growing Threat of Antimicrobial Resistance.

Munita JM, Shelburne S, Greenberg DE, Arias CA.

Tex Med. 2017 Feb 1;113(2):48-52.

PMID:
28207079
20.

Antibiotic-Induced Depletion of Anti-inflammatory Clostridia Is Associated with the Development of Graft-versus-Host Disease in Pediatric Stem Cell Transplantation Patients.

Simms-Waldrip TR, Sunkersett G, Coughlin LA, Savani MR, Arana C, Kim J, Kim M, Zhan X, Greenberg DE, Xie Y, Davies SM, Koh AY.

Biol Blood Marrow Transplant. 2017 May;23(5):820-829. doi: 10.1016/j.bbmt.2017.02.004. Epub 2017 Feb 9.

21.

Identification and Whole Genome Sequencing of the First Case of Kosakonia radicincitans Causing a Human Bloodstream Infection.

Bhatti MD, Kalia A, Sahasrabhojane P, Kim J, Greenberg DE, Shelburne SA.

Front Microbiol. 2017 Jan 24;8:62. doi: 10.3389/fmicb.2017.00062. eCollection 2017.

22.

Inhibition of Pseudomonas aeruginosa by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers.

Howard JJ, Sturge CR, Moustafa DA, Daly SM, Marshall-Batty KR, Felder CF, Zamora D, Yabe-Gill M, Labandeira-Rey M, Bailey SM, Wong M, Goldberg JB, Geller BL, Greenberg DE.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e01938-16. doi: 10.1128/AAC.01938-16. Print 2017 Apr.

23.

Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) restores carbapenem susceptibility to NDM-1-positive pathogens in vitro and in vivo.

Sully EK, Geller BL, Li L, Moody CM, Bailey SM, Moore AL, Wong M, Nordmann P, Daly SM, Sturge CR, Greenberg DE.

J Antimicrob Chemother. 2017 Mar 1;72(3):782-790. doi: 10.1093/jac/dkw476.

24.

Sequence-Specific Targeting of Bacterial Resistance Genes Increases Antibiotic Efficacy.

Ayhan DH, Tamer YT, Akbar M, Bailey SM, Wong M, Daly SM, Greenberg DE, Toprak E.

PLoS Biol. 2016 Sep 15;14(9):e1002552. doi: 10.1371/journal.pbio.1002552. eCollection 2016 Sep.

25.

Primary osteomyelitis caused by hypervirulent Klebsiella pneumoniae.

Prokesch BC, TeKippe M, Kim J, Raj P, TeKippe EM, Greenberg DE.

Lancet Infect Dis. 2016 Sep;16(9):e190-e195. doi: 10.1016/S1473-3099(16)30021-4. Epub 2016 Jul 9. Review.

PMID:
27402393
26.

Methylotroph Infections and Chronic Granulomatous Disease.

Falcone EL, Petts JR, Fasano MB, Ford B, Nauseef WM, Neves JF, Simões MJ, Tierce ML 4th, de la Morena MT, Greenberg DE, Zerbe CS, Zelazny AM, Holland SM.

Emerg Infect Dis. 2016 Mar;22(3):404-9. doi: 10.3201/eid2203.151265.

27.

Simultaneous Host-Pathogen Transcriptome Analysis during Granulibacter bethesdensis Infection of Neutrophils from Healthy Subjects and Patients with Chronic Granulomatous Disease.

Greenberg DE, Sturdevant DE, Marshall-Batty KR, Chu J, Pettinato AM, Virtaneva K, Lane J, Geller BL, Porcella SF, Gallin JI, Holland SM, Zarember KA.

Infect Immun. 2015 Nov;83(11):4277-92. doi: 10.1128/IAI.00778-15. Epub 2015 Aug 17.

28.

Acinetobacter infections and outcomes at an academic medical center: a disease of long-term care.

Townsend J, Park AN, Gander R, Orr K, Arocha D, Zhang S, Greenberg DE.

Open Forum Infect Dis. 2015 Mar 12;2(1):ofv023. doi: 10.1093/ofid/ofv023. eCollection 2015 Jan. Erratum in: Open Forum Infect Dis. 2015 Jan;2(1):ofv041.

29.

Microbiological culture methods for pediatric musculoskeletal infection: a guideline for optimal use.

Section J, Gibbons SD, Barton T, Greenberg DE, Jo CH, Copley LA.

J Bone Joint Surg Am. 2015 Mar 18;97(6):441-9. doi: 10.2106/JBJS.N.00477.

PMID:
25788299
30.

A 60-year-old man with necrotic skin lesions after heart transplantation.

Prokesch BC, Cavuoti D, Le JB, Greenberg DE.

Am J Transplant. 2014 Nov;14(11):2664-6. doi: 10.1111/ajt.12967. No abstract available.

31.

Peptide-conjugated phosphorodiamidate morpholino oligomers: a new strategy for tackling antibiotic resistance.

Geller BL, Greenberg DE.

Ther Deliv. 2014 Mar;5(3):243-5. doi: 10.4155/tde.13.145. No abstract available.

PMID:
24592949
32.

Draft Genome Sequences of Burkholderia cenocepacia ET12 Lineage Strains K56-2 and BC7.

Varga JJ, Losada L, Zelazny AM, Kim M, McCorrison J, Brinkac L, Sampaio EP, Greenberg DE, Singh I, Heiner C, Ashby M, Nierman WC, Holland SM, Goldberg JB.

Genome Announc. 2013 Oct 17;1(5). pii: e00841-13. doi: 10.1128/genomeA.00841-13.

33.

Gene-silencing antisense oligomers inhibit acinetobacter growth in vitro and in vivo.

Geller BL, Marshall-Batty K, Schnell FJ, McKnight MM, Iversen PL, Greenberg DE.

J Infect Dis. 2013 Nov 15;208(10):1553-60. doi: 10.1093/infdis/jit460. Epub 2013 Oct 14.

34.

Burkholderia cenocepacia J2315 escapes to the cytosol and actively subverts autophagy in human macrophages.

Al-Khodor S, Marshall-Batty K, Nair V, Ding L, Greenberg DE, Fraser ID.

Cell Microbiol. 2014 Mar;16(3):378-95. doi: 10.1111/cmi.12223. Epub 2013 Nov 6.

35.

Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis.

Sampaio EP, Hsu AP, Pechacek J, Bax HI, Dias DL, Paulson ML, Chandrasekaran P, Rosen LB, Carvalho DS, Ding L, Vinh DC, Browne SK, Datta S, Milner JD, Kuhns DB, Long Priel DA, Sadat MA, Shiloh M, De Marco B, Alvares M, Gillman JW, Ramarathnam V, de la Morena M, Bezrodnik L, Moreira I, Uzel G, Johnson D, Spalding C, Zerbe CS, Wiley H, Greenberg DE, Hoover SE, Rosenzweig SD, Galgiani JN, Holland SM.

J Allergy Clin Immunol. 2013 Jun;131(6):1624-34. doi: 10.1016/j.jaci.2013.01.052. Epub 2013 Mar 28.

36.

Draft genome sequence determination for cystic fibrosis and chronic granulomatous disease Burkholderia multivorans isolates.

Varga JJ, Losada L, Zelazny AM, Brinkac L, Harkins D, Radune D, Hostetler J, Sampaio EP, Ronning CM, Nierman WC, Greenberg DE, Holland SM, Goldberg JB.

J Bacteriol. 2012 Nov;194(22):6356-7. doi: 10.1128/JB.01306-12.

37.

Serologic reactivity to the emerging pathogen Granulibacter bethesdensis.

Greenberg DE, Shoffner AR, Marshall-Batty KR, Arora K, Zhao M, Martin R, Ding L, Hammer CH, Shaw PA, Kuhns DB, Malech HL, Gallin JI, Zarember KA, Holland SM.

J Infect Dis. 2012 Sep 15;206(6):943-51. doi: 10.1093/infdis/jis431. Epub 2012 Jul 10.

38.

Acidomonas methanolica-associated necrotizing lymphadenitis in a patient with chronic granulomatous disease.

Chase JM, Holland SM, Greenberg DE, Marshall-Batty K, Zelazny AM, Church JA.

J Clin Immunol. 2012 Dec;32(6):1193-6. doi: 10.1007/s10875-012-9728-6. Epub 2012 Jun 30.

39.

Innate immunity against Granulibacter bethesdensis, an emerging gram-negative bacterial pathogen.

Zarember KA, Marshall-Batty KR, Cruz AR, Chu J, Fenster ME, Shoffner AR, Rogge LS, Whitney AR, Czapiga M, Song HH, Shaw PA, Nagashima K, Malech HL, DeLeo FR, Holland SM, Gallin JI, Greenberg DE.

Infect Immun. 2012 Mar;80(3):975-81. doi: 10.1128/IAI.05557-11. Epub 2011 Dec 19.

40.

Recurrent Granulibacter bethesdensis infections and chronic granulomatous disease.

Greenberg DE, Shoffner AR, Zelazny AM, Fenster ME, Zarember KA, Stock F, Ding L, Marshall-Batty KR, Wasserman RL, Welch DF, Kanakabandi K, Sturdevant DE, Virtaneva K, Porcella SF, Murray PR, Malech HL, Holland SM.

Emerg Infect Dis. 2010 Sep;16(9):1341-8. doi: 10.3201/eid1609.091800.

41.

Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex.

Greenberg DE, Marshall-Batty KR, Brinster LR, Zarember KA, Shaw PA, Mellbye BL, Iversen PL, Holland SM, Geller BL.

J Infect Dis. 2010 Jun 15;201(12):1822-30. doi: 10.1086/652807.

42.

Host-microbe interaction systems biology: lifecycle transcriptomics and comparative genomics.

Sturdevant DE, Virtaneva K, Martens C, Bozinov D, Ogundare O, Castro N, Kanakabandi K, Beare PA, Omsland A, Carlson JH, Kennedy AD, Heinzen RA, Celli J, Greenberg DE, DeLeo FR, Porcella SF.

Future Microbiol. 2010 Feb;5(2):205-19. doi: 10.2217/fmb.09.125. Review. Erratum in: Future Microbiol. 2010 Mar;5(3):526. Ohmsland, Anders [corrected to Omsland, Anders].

43.

Recurrent Burkholderia infection in patients with chronic granulomatous disease: 11-year experience at a large referral center.

Greenberg DE, Goldberg JB, Stock F, Murray PR, Holland SM, Lipuma JJ.

Clin Infect Dis. 2009 Jun 1;48(11):1577-9. doi: 10.1086/598937.

44.

Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome.

Kim RD, Greenberg DE, Ehrmantraut ME, Guide SV, Ding L, Shea Y, Brown MR, Chernick M, Steagall WK, Glasgow CG, Lin J, Jolley C, Sorbara L, Raffeld M, Hill S, Avila N, Sachdev V, Barnhart LA, Anderson VL, Claypool R, Hilligoss DM, Garofalo M, Fitzgerald A, Anaya-O'Brien S, Darnell D, DeCastro R, Menning HM, Ricklefs SM, Porcella SF, Olivier KN, Moss J, Holland SM.

Am J Respir Crit Care Med. 2008 Nov 15;178(10):1066-74. doi: 10.1164/rccm.200805-686OC. Epub 2008 Aug 14.

45.

Immune function in young children with previous pulmonary or miliary/meningeal tuberculosis and impact of BCG vaccination.

Sterling TR, Martire T, de Almeida AS, Ding L, Greenberg DE, Moreira LA, Elloumi H, Torres AP, Sant'Anna CC, Calazans E, Paraguassu G, Gebretsadik T, Shintani A, Miller K, Kritski A, Lapa e Silva JR, Holland SM.

Pediatrics. 2007 Oct;120(4):e912-21.

PMID:
17908747
46.

Genome sequence analysis of the emerging human pathogenic acetic acid bacterium Granulibacter bethesdensis.

Greenberg DE, Porcella SF, Zelazny AM, Virtaneva K, Sturdevant DE, Kupko JJ 3rd, Barbian KD, Babar A, Dorward DW, Holland SM.

J Bacteriol. 2007 Dec;189(23):8727-36. Epub 2007 Sep 7.

47.

Granulibacter bethesdensis gen. nov., sp. nov., a distinctive pathogenic acetic acid bacterium in the family Acetobacteraceae.

Greenberg DE, Porcella SF, Stock F, Wong A, Conville PS, Murray PR, Holland SM, Zelazny AM.

Int J Syst Evol Microbiol. 2006 Nov;56(Pt 11):2609-16.

PMID:
17082400
48.

A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous disease.

Greenberg DE, Ding L, Zelazny AM, Stock F, Wong A, Anderson VL, Miller G, Kleiner DE, Tenorio AR, Brinster L, Dorward DW, Murray PR, Holland SM.

PLoS Pathog. 2006 Apr;2(4):e28. Epub 2006 Apr 14.

49.

Hematologic findings in children with rotavirus-positive and -negative diarrhea.

Greenberg DE, Wilimas JA, Buckingham SC.

Pediatr Hematol Oncol. 2003 Sep;20(6):453-6. Review. Erratum in: Pediatr Hematol Oncol. 2004 Mar;21(2):197. Green, D [corrected to Greenberg, David E].

PMID:
14631619
50.

Surgical cricothyroidotomy in trauma patients.

Wright MJ, Greenberg DE, Hunt JP, Madan AK, McSwain NE Jr.

South Med J. 2003 May;96(5):465-7.

PMID:
12911185

Supplemental Content

Loading ...
Support Center